NATCO PHARMA LTD. - NATCO launches VELPANAT in Nepal- 1st generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combination medicine in the country
Download 
|
< Back |
| 02 Jan 2017 | |
| Natco Pharma Ltd has informed BSE regarding a Press Release dated January 02, 2017 titled "NATCO launches VELPANAT in Nepal- 1st generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combination medicine in the country". | |
| View all announcements for NATCO PHARMA LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback